AU2002232558A1 - Compounds, compositions and methods for treatment of parasitic infections - Google Patents
Compounds, compositions and methods for treatment of parasitic infectionsInfo
- Publication number
- AU2002232558A1 AU2002232558A1 AU2002232558A AU3255802A AU2002232558A1 AU 2002232558 A1 AU2002232558 A1 AU 2002232558A1 AU 2002232558 A AU2002232558 A AU 2002232558A AU 3255802 A AU3255802 A AU 3255802A AU 2002232558 A1 AU2002232558 A1 AU 2002232558A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- compounds
- treatment
- methods
- parasitic infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25522100P | 2000-12-12 | 2000-12-12 | |
US60/255,221 | 2000-12-12 | ||
PCT/US2001/048032 WO2002048097A1 (en) | 2000-12-12 | 2001-12-11 | Compounds, compositions and methods for treatment of parasitic infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002232558A1 true AU2002232558A1 (en) | 2002-06-24 |
Family
ID=22967366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002232558A Abandoned AU2002232558A1 (en) | 2000-12-12 | 2001-12-11 | Compounds, compositions and methods for treatment of parasitic infections |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020107266A1 (en) |
AU (1) | AU2002232558A1 (en) |
WO (1) | WO2002048097A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5180550A1 (en) | 1999-04-19 | 2002-07-30 | Smithkline Beecham Corp | FAB I INHIBITORS |
CO5370679A1 (en) | 1999-06-01 | 2004-02-27 | Smithkline Beecham Corp | FAB INHIBITORS 1 |
PE20010635A1 (en) | 1999-10-08 | 2001-08-15 | Smithkline Beecham Corp | USEFUL FAB I INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS |
US6762201B1 (en) | 1999-10-08 | 2004-07-13 | Affinium Pharmaceuticals, Inc. | Fab I inhibitors |
US7700341B2 (en) | 2000-02-03 | 2010-04-20 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
AU2002305052A1 (en) | 2001-03-13 | 2002-09-24 | Corvas International, Inc. | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
JP2004535166A (en) | 2001-03-22 | 2004-11-25 | デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー | Nucleic acid molecule encoding serine protease CVSP14, encoded polypeptide and methods based thereon |
NZ527971A (en) | 2001-03-27 | 2006-03-31 | Dendreon Corp | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
ES2320984T3 (en) | 2001-04-06 | 2009-06-01 | Affinium Pharmaceuticals, Inc. | FAB INHIBITORS I. |
WO2002092841A2 (en) | 2001-05-14 | 2002-11-21 | Dendreon San Diego Llc | Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
BRPI0503951A (en) * | 2005-07-15 | 2007-03-06 | Fundacao De Amparo A Pesquisa | process of obtaining synthetic and semi-synthetic derivatives of lignans, their antiparasitic activities and their pharmaceutical formulations, encompassing the therapeutic method using such lignans in the treatment of parasitic diseases. |
EP2054422B1 (en) | 2006-07-20 | 2017-06-14 | Debiopharm International SA | Acrylamide derivatives as fab i inhibitors |
US8263613B2 (en) | 2007-02-16 | 2012-09-11 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab I inhibitors |
UY32827A (en) * | 2009-08-12 | 2011-02-28 | Glaxo Group Ltd | CATEPSIN C INHIBITORS |
CN103491777B (en) * | 2011-02-11 | 2015-05-06 | 葛兰素史密斯克莱知识产权发展有限公司 | Cathepsin c inhibitors |
NZ702695A (en) | 2012-06-19 | 2015-10-30 | Debiopharm Int Sa | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
WO2017137448A1 (en) | 2016-02-10 | 2017-08-17 | Axiava Pharma Ug | Dipeptidyl aldehydes for the treatment and/or prevention of parasitic diseases |
US10751351B2 (en) | 2016-02-26 | 2020-08-25 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
WO2023165334A1 (en) * | 2022-03-01 | 2023-09-07 | 成都威斯克生物医药有限公司 | Keto amide derivatives and pharmaceutical use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112759A0 (en) * | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
EP0817778A1 (en) * | 1995-03-24 | 1998-01-14 | Arris Pharmaceutical Corporation | Reversible protease inhibitors |
ES2293651T3 (en) * | 1995-11-28 | 2008-03-16 | Cephalon, Inc. | INHIBITORS OF CYSTEINE AND SERINE PROTEASES DERIVED FROM AMINO ACIDS D. |
US6150378A (en) * | 1997-10-07 | 2000-11-21 | Cephalon, Inc. | Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors |
JP2002539190A (en) * | 1999-03-15 | 2002-11-19 | アクシス・ファーマシューティカルズ・インコーポレイテッド | Novel compounds and compositions as protease inhibitors |
-
2001
- 2001-12-11 AU AU2002232558A patent/AU2002232558A1/en not_active Abandoned
- 2001-12-11 US US10/014,171 patent/US20020107266A1/en not_active Abandoned
- 2001-12-11 WO PCT/US2001/048032 patent/WO2002048097A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002048097A1 (en) | 2002-06-20 |
WO2002048097B1 (en) | 2003-02-20 |
US20020107266A1 (en) | 2002-08-08 |
WO2002048097A9 (en) | 2003-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03003168A (en) | Topical antibiotic composition for treatment of eye infection. | |
GB0125222D0 (en) | Composition for the treatment of microbial infections | |
AU2002232558A1 (en) | Compounds, compositions and methods for treatment of parasitic infections | |
AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
AU2002329884A1 (en) | Processed soft tissue for topical or internal application | |
AU2001233081A1 (en) | Composition for treatment of stress | |
AU2001272852A1 (en) | Composition for the treatment of migraine | |
ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
AU2003270498A1 (en) | Topical veterinary compositions and methods for the treatment and prevention of infection | |
AU2001286983A1 (en) | Method of treatment | |
AU2002364964A1 (en) | Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections | |
AU2003296963A1 (en) | Methods and compositions for treating and preventing ear infections | |
AU2003239132A1 (en) | Methods and compositions for preventing and treating microbial infections | |
AU2003259202A1 (en) | Compositions and methods for treating and preventing infection | |
AU2002365083A1 (en) | Composition and method to treat viral bacterial and parasitic infections and infestations | |
AU2002334761A1 (en) | Methods of treating drug-resistant bacterial infections | |
AU2003237088A1 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
AU2002302580A1 (en) | Use of phyllanthus constituents for treating or preventing infections caused by hepatit | |
AU2002242096A1 (en) | Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms | |
AU2001262177A1 (en) | Method of treatment | |
AU2003303948A1 (en) | Compositions and methods for preventing infection | |
AU2003275069A1 (en) | Compositions and methods for preventing infection | |
AU2001258675A1 (en) | Treating infections |